Clinical Features of Acute Myeloid Leukemia (AML)
AML typically presents with symptoms of bone marrow failure including fever, generalized weakness, bleeding manifestations, and dyspnea, along with physical findings of pallor, and less commonly hepatosplenomegaly and lymphadenopathy 1, 2.
Presenting Symptoms
The most common clinical presentations reflect bone marrow failure and include:
- Fever (present in 72.8% of patients) - often due to neutropenia and infection 1
- Generalized weakness and fatigue (60% of patients) - secondary to anemia 1
- Bleeding manifestations (37.6% of patients) - including petechiae, ecchymoses, mucosal bleeding from thrombocytopenia 1
- Dyspnea (12% of patients) - related to severe anemia 1
The disease characteristically has a rapid onset and may be fatal within weeks to months if left untreated 2.
Physical Examination Findings
Key physical findings at presentation include:
- Pallor (56.8% of patients) - reflecting anemia 1
- Splenomegaly (16% of patients) 1
- Hepatomegaly (12.8% of patients) 1
- Lymphadenopathy (10.4% of patients) 1
Laboratory Abnormalities
Pancytopenia is the hallmark laboratory finding, with the following typical values 1, 3:
- Anemia: Mean hemoglobin 8.19 g/dL (normal MCV around 86 fL)
- Thrombocytopenia: Mean platelet count 62.3 × 10⁹/L
- Variable leukocyte count: Can range from leukopenia to marked leukocytosis (mean 43.1 × 10⁹/L), with circulating blasts
- Neutropenia: Mean absolute neutrophil count 3.09 × 10⁹/L
- Coagulation abnormalities: Particularly in acute promyelocytic leukemia variants 4
Bone Marrow Findings
Bone marrow examination reveals 3:
- ≥20% myeloid blasts (diagnostic threshold per WHO classification) 5
- Significant proliferation of hematopoietic cells
- Impaired normal hematopoiesis 2
Demographic Patterns
- Age: Predominantly affects older adults (>60 years), though can occur at any age 2
- Gender: Male predominance with approximately 1.5:1 male-to-female ratio 1
- Geographic variation: Pakistani patients present at younger mean age (38.8 years) compared to Western populations 1
Important Clinical Pitfalls
The rapid progression of AML demands urgent recognition. Unlike chronic leukemias, the acute presentation with bone marrow failure symptoms developing over days to weeks is characteristic. The presence of circulating blasts on peripheral smear combined with cytopenias should trigger immediate bone marrow evaluation rather than waiting for symptom progression 2.